Young Jordanian treated for rare ‘Wilson’ disease

AMMAN — The Jordan Food and Drug Administration (JFDA) has provided treatment for a Jordanian youth Orwa Qawabaa at the Jordan University Hospital under the directives of the prime minister, the Jordan News Agency, Petra, reported on Thursday.

The JFDA said in a statement that the patient is suffering from the rare “Wilson” disease, for which the treatment is neither registered in Jordan nor in the region.

The administration noted that the treatment costs up to $80,000 and lasts for four months. The JFDA added that it has been in contact with the US manufacturer’s regional office, which provided the necessary treatment through an association affiliated with the manufacturer.

On Thursday, JFDA Director General Hayel Obeidat handed the treatment over to the hospital’s Director General Abdel-Aziz Ziadat and the patient’s family.